Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.

Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.